Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua F Baker

Showing results (81-90 of 245) with videos related to

Pageof 25
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2020
Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional IncentivesJoshua F Baker, Charles E Leonard, Vincent Lo Re, et al.
Arthritis Care & Research|March 26, 2014
Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritisJoshua F Baker, Joan Von Feldt, Sogol Mostoufi-Moab, et al.
Drugs & Therapy Perspectives : for Rational Drug Selection and Use|October 29, 2021
Knowledge of biosimilars and perceptions of the naming conventions for biosimilar products in clinical practice in the United StatesMarianna Olave, Criswell Lavery, Charles E Leonard, et al.
Epidemiology (Cambridge, Mass.)|September 25, 2021
Risk of Serious Infection With Low-dose Glucocorticoids in Patients With Rheumatoid Arthritis: An Instrumental Variable AnalysisMichael D George, Jesse Y Hsu, Sean Hennessy, et al.
Annals of the Rheumatic Diseases|August 2, 2013
Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trialJoshua F Baker, Mikkel Ostergaard, Paul Emery, et al.
Arthritis Care & Research|July 24, 2020
Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long-Term Use of GlucocorticoidsMichael D George, Joshua F Baker, Beth Wallace, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Association of Cardiovascular Outcomes With Low-Dose Glucocorticoid Prescription in Patients With Rheumatoid ArthritisBrian W Coburn, Joshua F Baker, Jesse Y Hsu, et al.
Seminars in Arthritis and Rheumatism|July 25, 2025
Weight loss, disease activity, and patient reported outcomes in patients with musculoskeletal and autoimmune diseases taking weight loss medications: a retrospective cohort studyThomas R Riley, Kristin Wipfler, Katherine D Wysham, et al.
BMC Musculoskeletal Disorders|September 5, 2015
Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care settingKashif Jafri, Lynne Taylor, Melissa Nezamzadeh, et al.
ACR Open Rheumatology|September 2, 2023
Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health SystemStephanie Jeong, Michael D George, Ted R Mikuls, et al.
Pageof 25

Showing results (81-90 of 245) with videos related to

Sort By:
Pageof 25
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2020
Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional IncentivesJoshua F Baker, Charles E Leonard, Vincent Lo Re, et al.
Arthritis Care & Research|March 26, 2014
Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritisJoshua F Baker, Joan Von Feldt, Sogol Mostoufi-Moab, et al.
Drugs & Therapy Perspectives : for Rational Drug Selection and Use|October 29, 2021
Knowledge of biosimilars and perceptions of the naming conventions for biosimilar products in clinical practice in the United StatesMarianna Olave, Criswell Lavery, Charles E Leonard, et al.
Epidemiology (Cambridge, Mass.)|September 25, 2021
Risk of Serious Infection With Low-dose Glucocorticoids in Patients With Rheumatoid Arthritis: An Instrumental Variable AnalysisMichael D George, Jesse Y Hsu, Sean Hennessy, et al.
Annals of the Rheumatic Diseases|August 2, 2013
Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trialJoshua F Baker, Mikkel Ostergaard, Paul Emery, et al.
Arthritis Care & Research|July 24, 2020
Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long-Term Use of GlucocorticoidsMichael D George, Joshua F Baker, Beth Wallace, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Association of Cardiovascular Outcomes With Low-Dose Glucocorticoid Prescription in Patients With Rheumatoid ArthritisBrian W Coburn, Joshua F Baker, Jesse Y Hsu, et al.
Seminars in Arthritis and Rheumatism|July 25, 2025
Weight loss, disease activity, and patient reported outcomes in patients with musculoskeletal and autoimmune diseases taking weight loss medications: a retrospective cohort studyThomas R Riley, Kristin Wipfler, Katherine D Wysham, et al.
BMC Musculoskeletal Disorders|September 5, 2015
Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care settingKashif Jafri, Lynne Taylor, Melissa Nezamzadeh, et al.
ACR Open Rheumatology|September 2, 2023
Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health SystemStephanie Jeong, Michael D George, Ted R Mikuls, et al.
Pageof 25